7 Investor presentation First nine months of 2020 Diabetes value market leadership Novo Nordisk global diabetes value market share 60% Diabetes GLP-1 Insulin 50% 48.8% 42.4% 40% 46.7% 44.3% 49.9% 44.5% 30% 27.4% 28.4% 29.2% 20% 2018 2019 New generation insulins include: Tresiba®, Ryzodeg®, Fiasp® and Xultophy® CER: Constant exchange rates Source: IQVIA MAT, Aug 2020 Note: Unless otherwise specified, sales growth are at CER 2020
Download PDF file